China Zoledronic Acid Market

Malignancy with bone metastases is common in patients with advanced tumor like breast cancer, lung cancer, prostate cancer and multiple myeloid. Since patients with breast cancer or prostate cancer have relatively long median survival time, they still face the problem of treating bone metastases.

Meanwhile, patients with lung cancer also need to pay attention to bone metastases despite their short median survival due to lung cancer’s high incidence. The complications of bone metastases include bony pain, pathological fracture, spinal cord compression and hyperglycemia. The most common drug for bone metastases is Diophantine. Three generations of Diophantine, respectively, deteriorate and chlorinated represented by Bones, pomegranate and Laundromat sodium represented by Bobbin as well as sodium abandoner and Caledonia acid are now used in the clinic. View Full Report at: http://www. Nonrepresentational. Is/analysis/294422 Developed by Innovation, Caledonia acid first appeared in the market in Canada in Cot. 2000 and then in May, it entered Britain. In Jug. 2001, it was approved by FDA to be sold under the trade name of Zoomed. As the new generation of Diophantine, Caledonia acid can inhibit the activity of seacoasts, slow down bone restriction and reduce the incidence of bone metastases in cancer patients. Compared with pomegranate,

Caledonia acid is more effective in inhibiting hyperglycemia in patients tit multiple myeloid or solid tumor, alleviating pain, delaying bone metastases and other complications.

Each year, the number of new cases of cancer in China reaches more than 3 million, among which about 50% is with bone metastases. Caledonia acid develops fast after entering China, annual sales value rising from less than CCNY 12 million in 2005 to CCNY 474 million in 2014 and CARR during this period reaching 52%. Innovation (Switzerland), Chic ATA Attaining Pharmaceutical Group Co. , Ltd, Jungian Henning Medicine Co. , Ltd, Chuan Hearing Pharmaceutical Co. Ltd and Jill Province Oxidant Pharmaceutical Sic-Tech Development Co. Ltd occupy the majority of the market share, among which Innovation (Switzerland) has the largest market share of over 70% for sales value in 2014. Download Detail Report With Complete TCO at: http://www. Nonrepresentational. Biz/sample/sample/294422 Readers can get at least the following information from this report: market size of Caledonia acid in China competitive landscape of Caledonia acid in Chinese market price of Caledonia acid made by different enterprises in China market outlook of

China Caledonia Acid Market By rasher_27 The author suggests the following groups of people purchase this report: manufacturers of anti-tumor drugs investors/ research institutions interested in Chinese medicine market any interest in the Chinese medicine market, please contact CRIB for customized survey service Table of Content 1 Related Concepts of Caledonia Acid 1. 1 Indication 1. 2 Sales Status in Global Market 2 Market Profile of Caledonia Acid in China 2. 1 Patent and Approval Status of Caledonia Acid in China 2. 2 Major Manufacturers 2. 3 Market Size Survey on Sales Status of Caledonia Acid in China, 2010-2014 3. Sales Value 3. 1. 1 Overall Sales Value 3. 1. 2 Sales Value by Regions 3. 2 Sales Volume 3. 2. 1 Overall Sales Volume 3. 2. 2 Sales Volume by Regions Browse all latest Articles of Market Research Reports at:http://www. Nonrepresentational. Biz/articles About us Nonrepresentational. Biz is the most comprehensive collection of market research reports. Nonrepresentational. Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services.